Migliaccio & Rathod LLP is investigating Proxima Health for promoting the Ayus plasma-filtration device before FDA clearance.

Reported Proxima Health Issues

Marketed “Ayus dual-membrane plasma filtration” for “microplastic detox” and “cellular rejuvenation.”
Advertised the device’s benefits while still undergoing FDA review.
Promoted “subtractive medicine” procedures in the U.S. without regulatory approval.

Why Consumers Should Be Concerned

Marketing medical devices or treatments prior to FDA approval may violate federal law and consumer-protection standards. Patients could face health risks or financial harm from unapproved medical interventions.

Signs You May Be Affected

You purchased or pre-ordered Ayus-based filtration treatments.
You were told the device was FDA-approved or medically proven.
You experienced side effects or financial loss after treatment.

If you underwent an Ayus filtration procedure through Proxima Health, contact [email protected] or (202) 470-3520 for a free consultation.

The following will ask for your contact information so that we may reach you to talk about potential claims. This information is for our records only and will not be shared. By continuing, you consent to the collection of this information for these limited purposes.

Your name Your phone number Your email State of Residence What is the name of the affected product or service? When did you last purchase this product or service (month and year)? Do you have proof of purchase (receipt, email confirmation, transaction on your bank statement, etc.)?

Please briefly describe the issue with the product or service and when it occurred.

Would you like to join our newsletter to receive notifications about other investigations we're looking into, as well as updates on ongoing cases?